MENU

Speakers


  • Dr. Alan Lam, PhD

    Dr. Alan Lam, PhD

    Senior Scientist, Bioprocessing Technology Institute A*STAR

    BIOGRAPHY
  • Dr. Qu Yinghua, PhD

    Dr. Qu Yinghua, PhD

    Field Application Scientist, Cell & Gene Therapy, SEATW Thermo Fisher Scientific

    BIOGRAPHY
  • Dr. Paula Lam, PhD

    Dr. Paula Lam, PhD

    Chief Scientific Officer, BioCell Innovations, Singapore

    BIOGRAPHY
  • Dr. Sylvie Shen, PhD

    Dr. Sylvie Shen, PhD

    Field Application Scientist, Cell & Gene Therapy, Australasia Thermo Fisher Scientific

    BIOGRAPHY
  • Shing-Mou Lee

    Shing-Mou Lee

    CEO & Lab Head, EMO Biomedicine Corp.

    BIOGRAPHY
  • Karolina Setyowati, Ph.D.

    Karolina Setyowati, Ph.D.

    Sr Product Specialist, APJ, Thermo Fisher Scientific

    BIOGRAPHY
  • Bingrong Chen

    Bingrong Chen

    Manager, Regulatory Affairs Thermo Fisher Scientific

    BIOGRAPHY
MARCH, 2024 - MARCH, 2025

Technology and Process Advancements in Cell and Gene Therapy Development

Join Thermo Fisher Scientific as we host a Cell and Gene Therapy Virtual Event on
Technology and process advancements in cell and gene therapy development! 

 

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness this potential, stakeholders across the CGT ecosystems must collaborate to overcome barriers to delivering life-changing treatment to patients. 

Delivered through an interactive virtual platform, this event features over three hours of insightful sessions led by 6 speakers. The discussions will provide industry perspectives on essential success factors for developing CGTs, covering topics such as:

  • Large scale processing of mesenchymal stem cells (MSC) and T cell immunotherapies
  • Integrated, cutting-edge solutions and process advancements that supports end-to-end workflow 
  • Regulatory considerations in raw material selection from research through commericalization 
  • Analytical platforms to evaluate the quality, safety, and efficacy of cell-based products

Don't missed the opportunity to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy sector through an Asian lens. We will cover topics on:

  • The industry outlook, bioanalytical landscape, and updates in cell therapy regulation
  • The importance of partnerships within the CGT ecosystem
  • Deciding on a commercially viable manufacturing model

Register today!


Speakers
  • Dr. Alan Lam, PhD

    Senior Scientist, Bioprocessing Technology Institute A*STAR
    BIOGRAPHY
  • Dr. Qu Yinghua, PhD

    Field Application Scientist, Cell & Gene Therapy, SEATW Thermo Fisher Scientific
    BIOGRAPHY
  • Dr. Paula Lam, PhD

    Chief Scientific Officer, BioCell Innovations, Singapore
    BIOGRAPHY
  • Dr. Sylvie Shen, PhD

    Field Application Scientist, Cell & Gene Therapy, Australasia Thermo Fisher Scientific
    BIOGRAPHY
  • Shing-Mou Lee

    CEO & Lab Head, EMO Biomedicine Corp.
    BIOGRAPHY
  • Karolina Setyowati, Ph.D.

    Sr Product Specialist, APJ, Thermo Fisher Scientific
    BIOGRAPHY
  • Bingrong Chen

    Manager, Regulatory Affairs Thermo Fisher Scientific
    BIOGRAPHY

You May Also Like

Agenda

Help

Loading Comments...